Comparative Study
[A study of the safety of probiotic bacilli]
[Article in
Russian]
- PMID: 16496957
Item in Clipboard
Comparative Study
[A study of the safety of probiotic bacilli]
[Article in
Russian]
Vestn Ross Akad Med Nauk.
2006.
Abstract
The aim of the study was to evaluate the biological safety of a range of probiotic bacilli, ingredients of the commercial preparations biosporin, bactisubtil, and irilis; their biological effects were scrutinized in an animal experiment. The study demonstrated that the strains B. subtilis 3, 07, and B. licheniformis 31, 09, ingredients of biosporin and irilis, unlike B. cereus IP 5832, an ingredient of bactisubtil, were not toxic, toxigenic, or virulent, and did not impair the antitoxic hepatic function, which allows considering them to be safe.
Similar articles
-
[Pre-clinical trials of new spore probiotics].Vestn Ross Akad Med Nauk. 2005;(12):36-40. Vestn Ross Akad Med Nauk. 2005. PMID: 16404982 Russian.
-
[A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations].Mikrobiol Z. 1997 Nov-Dec;59(6):43-9. Mikrobiol Z. 1997. PMID: 9511375 Russian.
-
[Safety of bacteria of the genus Bacillus, forming the base of some probiotics].Zh Mikrobiol Epidemiol Immunobiol. 1998 Nov-Dec;(6):68-70. Zh Mikrobiol Epidemiol Immunobiol. 1998. PMID: 9949507 Russian.
-
[Outlook for using bacteria of the genus Bacillus for the design of new biopreparations].Antibiot Khimioter. 1996;41(10):13-5. Antibiot Khimioter. 1996. PMID: 9027285 Review. Russian.
-
Literature review on the safety of Toyocerin, a non-toxigenic and non-pathogenic Bacillus cereus var. toyoi preparation.Regul Toxicol Pharmacol. 2009 Nov;55(2):236-46. doi: 10.1016/j.yrtph.2009.07.009. Epub 2009 Jul 23. Regul Toxicol Pharmacol. 2009. PMID: 19631708 Review.